Records containing: Polymyositis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-09-21
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
CLINICAL_TRIALS study record update · 2026-07-24
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
CLINICAL_TRIALS study record update · 2026-04-24
Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies
CLINICAL_TRIALS study record update · 2026-04-23
A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
CLINICAL_TRIALS study record update · 2026-04-20
Environmental Risk Factors for the Anti-Synthetase Syndrome
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-04-07
A PHASE 3, MULTI-CENTER, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF DAZUKIBART IN PARTICIPANTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH DERMATOMYOSITIS OR POLYMYOSITIS)
CLINICAL_TRIALS study record update · 2026-03-31
Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
CLINICAL_TRIALS study record update · 2026-03-23
Correlation of "Myositis Functional Index-3 (Fi-3)" With Muscle Function Assessed by Isokinetic Dynamometry and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
CLINICAL_TRIALS study record update · 2026-02-27
Treatment With add-on IVIg in Myositis Early In the diSease Course May be sUperior to Steroids Alone for Reaching CLinical improvemEnt
CLINICAL_TRIALS study record update · 2026-02-17
Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
CLINICAL_TRIALS study record update · 2026-02-13
Rheumatology Patient Registry and Biorepository
CLINICAL_TRIALS study record update · 2026-01-28
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) - A Qualitative Study of Patient-voiced Research Priorities Across Rare Myositis Diseases
CLINICAL_TRIALS study record update · 2025-12-22
Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
CLINICAL_TRIALS study record update · 2025-09-30
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
CLINICAL_TRIALS study record update · 2025-08-14
A Prospective, Multi-center, Randomized, Double-blinded, Placebo-controlled, Parallel, Phase 2 Trial to Evaluate the Efficacy, Safety of PN-101(Mitochondria Isolated From Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells) Single Dose in Patients With Refractory Polymyositis or Dermatomyositis
CLINICAL_TRIALS study record update · 2025-07-23
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
CLINICAL_TRIALS study record update · 2025-07-17
A Phase IIa, Randomized, Parallel, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Enpatoran in Dermatomyositis and Polymyositis Participants Receiving Standard of Care (NEPTUNIA)
CLINICAL_TRIALS study record update · 2025-04-11
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
CLINICAL_TRIALS study record update · 2025-01-24
Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)
CLINICAL_TRIALS study record update · 2024-12-13
A Phase 1 Randomized, Placebo-Controlled, Blinded, Multiple Ascending Dose Study to Evaluate VIB7734 in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
CLINICAL_TRIALS study record update · 2024-06-05
An Open-label Extension to the Phase 2 Randomized, Double-blind, Placebo-controlled, Crossover Multicenter Study to Evaluate the Safety and Efficacy of KZR-616 in the Treatment of Patients With Active Polymyositis or Dermatomyositis
CLINICAL_TRIALS study record update · 2024-05-13
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
CLINICAL_TRIALS study record update · 2024-04-17
Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases
CLINICAL_TRIALS study record update · 2024-04-10
High-intensity Strength Training in Patients With Idiopathic Inflammatory Myopathies: Changes in Quality of Life, Muscle Strength, Function and Myocellular Parameters
CLINICAL_TRIALS study record update · 2024-04-03
A Prospective, Open, Dose-escalation, Multi-center, Phase 1/2a Trial to Evaluate the Safety, Tolerability and to Explore the Efficacy of PN-101 in Patients With Refractory Polymyositis or Dermatomyositis